Subscribe to news

HSCI's Board of Directors Recommends No Dividends Be Paid for 2012

Moscow, 20 May 2013 – OJSC HSCI – The Human Stem Cells Institute (“HSCI”, MICEX: ISKJ), one of Russia’s leading biotech companies specializing in cell-based, gene and post-genome technologies, today announced the decision of the Company’s Board of Directors on the agenda of the Annual General Shareholders’ Meeting upon the results of 2012.

HSCI’s Annual General Shareholders’ Meeting (hereinafter – AGM) will be held at 11 a. m. on June 20, 2013, at the Ladoga hall of Renaissance Moscow Hotel located at 18/1, Olympiysky prospect, Moscow, Russian Federation.

Shareholders as of record on May 6, 2013, will be entitled to participate in the AGM.

As HSCI reported a net loss in 2012 (see the press-release in HSCI’s FY2012 results under RAS: http://eng.hsci.ru/news/press-relizy/hsci-reports-full-year-2012-ras-results), the Board of Directors has recommended that the AGM make a decision not to pay annual dividends.


20 May 2013